Health Canada inspection
GlaxoSmithKline Inc.: Health Canada inspection of Sep 12, 2025
Health Canada · GMP · rating C
Key facts
| Establishment | GlaxoSmithKline Inc. |
|---|---|
| City | Mississauga |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Sep 11, 2025 |
| End date | Sep 12, 2025 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 100630 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.